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Abstract
dsRNA is the genetic material of important viruses and a key component of RNA interference- based immunity in eukaryotes. 
Previous studies have noted difficulties in determining the sequence of dsRNA molecules that have affected studies of immune 
function and estimates of viral diversity in nature. DMSO has been used to denature dsRNA prior to the reverse- transcription 
stage to improve reverse transcriptase PCR and Sanger sequencing. We systematically tested the utility of DMSO to improve 
the sequencing yield of a dsRNA virus (Φ6) in a short- read next- generation sequencing platform. DMSO treatment improved 
sequencing read recovery by over two orders of magnitude, even when RNA and cDNA concentrations were below the limit 
of detection. We also tested the effects of DMSO on a mock eukaryotic viral community and found that dsRNA virus reads 
increased with DMSO treatment. Furthermore, we provide evidence that DMSO treatment does not adversely affect recovery of 
reads from a ssRNA viral genome (influenza A/California/07/2009). We suggest that up to 50 % DMSO treatment be used prior 
to cDNA synthesis when samples of interest are composed of or may contain dsRNA.
DaTa SuMMary
Sequence data was deposited in the National Center for 
Biotechnology Information Short Read Archive (accession 
numbers: PRJNA527100, PRJNA527101, PRJNA527098). 
Data and code for analysis is available at GitHub (https:// 
github. com/ awilcox83/ dsRNA- sequencing/) (https:// dx. 
doi. org/ 10. 5281/ zenodo. 3530803). The protocol for dsRNA 
sequencing has been posted on  protocols. io (http:// dx. doi. 
org/ 10. 17504/ protocols. io. ugnetve).
InTrODucTIOn
RNA is a ubiquitous biological molecule involved in tran-
scription and translation, which also serves as the genetic 
material of a large number of important viruses. The double- 
stranded form of RNA (dsRNA) is believed to be less abun-
dant in nature, but is a crucial component of a number of 
biological systems. It has a central role in the RNA interfer-
ence system [1], which modulates innate immunity in plants 
and animals, and serves as a replicative intermediate of (+) 
ssRNA viruses, while also being present in dsDNA and (−) 
ssRNA infections [2]. Moreover, it also serves as the genetic 
material of a number of virus lineages (including the families 
Reoviridae, Cystoviridae and Picobirnaviridae) that infect 
humans, animals, plants, fungi and bacteria, which play 
important medical, ecological and scientific roles. A number 
of dsRNA viruses are of clinical and agricultural significance, 
such as Bluetongue virus, which causes high morbidity and 
mortality in ruminants [3], and rotavirus, which causes acute 
gastroenteritis in humans [4]. There are indications that the 
overall diversity of RNA viruses may be underestimated [5, 6] 
and difficulties sequencing dsRNA in particular have been 
noted in the literature [7, 8]. As a consequence, dsRNA virus 
lineages may be under- represented and dsRNAs involved in 
immunity may be underestimated.
THEOry anD IMplEMEnTaTIOn
The extent of microbial diversity has been revealed by 
powerful whole- genome sequencing tools that are quickly 
becoming standard tools in biology. However, next- generation 
sequencing has known biases according to the nucleic acid 
composition [9]. A major limitation is that most sequencing 
platforms cannot sequence RNA directly, requiring that it 
is first reverse- transcribed into its cDNA. cDNA synthesis 
is typically achieved by hybridizing oligonucleotide DNA 
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primers to the RNA and using a reverse transcriptase to 
synthesize the remainder of the cDNA strand. This step poses 
a particular problem to dsRNA, because the presence of a 
complementary strand blocks the ability of these primers to 
bind. The blocking has a direct effect on the amount of dsRNA 
converted to cDNA, resulting in many fewer sequencing reads 
being generated relative to the true amount of RNA present. 
Additionally, many dsRNA viruses have small genomes 
that limit the amount of RNA that can be extracted, further 
complicating the determination of dsRNA sequences.
As early as 1968, DMSO had been shown to have a denaturing 
effect on nucleic acids [10]. DMSO has been successfully used 
to improve the performance of reverse transcriptase PCR [11] 
and Sanger sequencing [12]. However, to our knowledge 
DMSO has not been used for next- generation sequencing 
approaches and many dsRNA sequencing studies omit DMSO 
treatment [7, 13–15]. Moreover, there is no standard protocol 
for DMSO treatment of samples and previous methods vary 
greatly in their conditions, particularly DMSO concentration, 
which has ranged from 15 % [12] to 90 % [16].
This work investigated four questions regarding the effect of 
DMSO treatment on next- generation sequencing. (i) Does 
DMSO treatment improve recovery of dsRNA reads and at 
what concentration? (ii) Does DMSO affect read coverage 
and accuracy of a viral genome? (iii) Is the effect of DMSO 
independent of RNA concentration? (iv) Does DMSO treat-
ment negatively affect the recovery of ssRNA genomes? Our 
results suggest that treatment with a high concentration of 
DMSO greatly increases the number of reads generated when 
sequencing dsRNA with no effect on read accuracy, without 
adversely affecting sequencing of ssRNA virus genomes on 
the Illumina short- read sequencing platform.
We carried out the methods in this paper on two different 
viruses: Pseudomonas phage Φ6, which has a dsRNA genome 
made up of three segments, and human influenza virus A 
H1N1, which contains eight ssRNA segments. We also used 
a mock eukaryotic viral community, manufactured by the 
National Institute for Biological Standards and Control 
(NIBSC, UK), as a reference material for multiplex viral 
detection (NIBSC reagent 11/242–001). This reagent was 
expected to contain 25 human pathogenic viruses and has 
been used to investigate viral detection methods on mixed 
and metagenomic samples [17].
Sample preparation
Φ6 lysate was prepared by plating the phage and its Pseu-
domonas syringae host using double agar overlay. Phages 
were harvested by selecting a plate with semi- confluent lysis, 
transferring the soft agar layer to 3 ml LB (Lennox) media, 
and centrifuging to remove host cells and agar. An influenza 
virus lysate was generated from an egg- passaged stock of 
influenza A/California/07/2009 (H1NI) (generously provided 
by Ted M. Ross, University of Georgia, GA, USA), which was 
expanded by passage at a low m.o.i. in Madin–Darby canine 
kidney (MDCK) cells in culture. Viral lysates and the mock 
viral community (NIBSC reagent 11/242–001) were passed 
through a 0.22 µm Millipore polyethersulfone membrane 
filter (Millex) to remove debris and contaminants. Each 
filtrate (1 ml) was treated with 25 µl DNAse I (Thermo Scien-
tific) and 50 µl RNAse A/T1 mix (Thermo Scientific) with 1× 
DNAse I buffer (Thermo Scientific) at 37 °C for 1 h 30 min to 
degrade extracapsular nucleic acids. Viral RNA was extracted 
using an RNeasy mini kit (Qiagen), passing a total of 900 µl 
nuclease- treated lysate through a column, and eluting into 
100 µl elution buffer.
DMSO treatment, reverse transcription and 
sequencing
Viral RNA samples were divided into 20 µl aliquots. DMSO 
was added to concentrations of 15, 50 and 90 (v/v) % for each 
sample, followed by 1 h and 30 min of incubation at 65 °C. 
DMSO was removed using a RNeasy MinElute cleanup kit 
(Qiagen), following the manufacturer’s instructions. An 
additional sample was treated by heat denaturation but not 
DMSO: the tube containing the RNA extraction was placed in 
boiling water for 5 min [18]. Following this, all samples were 
placed on ice until cDNA synthesis was carried out. Other 
than heat or DMSO treatment, the treatment of all samples 
followed standard cDNA synthesis methods.
First- strand cDNA synthesis was carried out as described in 
the SuperScript III first- strand cDNA synthesis kit (Fisher) 
instructions, by adding 5 µl each RNA sample (including a 
control that had not undergone DMSO treatment or column 
clean- up) to 1 µl random hexamer oligos, 1 µl dNTPs and 
3 µl DEPC- treated water. Reactions were incubated at 65 °C 
for 5 min, then placed on ice for 1 min. Reverse transcriptase 
buffer (1×), 5 mM MgCl2, 0.01 M DTT, 1 µl RNAseOUT and 
1 µl SuperScript III RT enzyme were added to each reaction 
to a total volume of 20 µl. Reactions were incubated in a 
thermal cycler at 25 °C for 10 min, 50 °C for 50 min and 85 °C 
for 5 min. Second- strand synthesis was carried out by adding 
Impact Statement
dsRNA is the genetic material of important viruses and 
a key component of RNA interference- based immunity 
in eukaryotes. However, it is difficult to determine the 
genetic sequence of this critical nucleic acid using new 
high- throughput sequencing techniques. We developed a 
simple protocol using a cheap reagent that dramatically 
improves dsRNA sequencing coverage without affecting 
accuracy and sequencing of other RNA molecules. This 
method will impact three areas important for research 
into human, animal, agricultural and ecological health, 
by enabling sequencing of: (i) dsRNA viruses known to 
infect humans, animals, plants, fungi and bacteria; (ii) 
key dsRNA molecules that mediate human, animal and 
plant defences against pathogens through the immune 
system; and (iii) undiscovered viruses in our microbi-
omes and other natural and engineered environments.
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Table 1. The total number of reads generated during sequencing of 
influenza and Φ6 after treatment at varying DMSO concentrations, and 
the number of those reads that mapped to reference genomes
DMSO 
(%)
Total no. of reads Reads that map 
to Φ6
Reads that map 
(%)
0 1 551 220 1 377 0.1
15 1 314 520 10 358 0.8
50 1 077 133 263 993 24.5
90 1 393 569 224 562 16.1
1 µl dNTPs, 0.5 µl DNA ligase, 2 µl DNA polymerase I, 0.5 µl 
RNAse H in 1× second- strand synthesis buffer, made up to 
a total volume of 40 µl with nuclease- free water. Reactions 
were incubated at 16 °C for 5 h and cDNA was purified with 
a NucleoSpin gel and PCR clean- up kit (Macherey- Nagel). 
Libraries were prepared for Illumina sequencing using the 
Nextera XT DNA sample preparation kit (Illumina), with a 
1/5 ‘scaled’ library preparation protocol after that of Baym 
et al. [19].
Bioinformatics
Reads were trimmed for adapters and quality using Cuta-
dapt [20] and Sickle [21]. Due to a short fragment size, reads 
overlapped and so paired- end libraries were merged into 
single- end libraries using pear [22]. For Φ6 and influenza 
virus lysates, these libraries were mapped to the reference 
genomes using Bowtie2 [23], and Bam- readcount [24] was 
used to determine the read depth at each position. Plots were 
generated using the ggplot2 package in R.
For the mock viral community, a custom virus discovery pipe-
line was used to analyse sequencing reads [25]. Reads were 
translated and aligned to a viral proteome database (consisting 
of all annotated full or near- full viral genomes) using blastx. 
The significant hits to the virus database were then aligned 
to a non- virus- non- redundant (NVNR) universal proteome 
database using blastx. Hits with a more significant E value 
to NVNR than to the virus database were removed.
To test whether DMSO treatment had any effect on sequencing 
fidelity, we used two approaches to estimate sequencing error 
rates. First, we used Freebayes [26] to generate a vcf file 
containing all differences from the reference genome with a 
frequency of <5 % and a Phred quality score of at least 30. A 
custom Python script was used to count the number of these 
mutations and the total bases sequenced for each sample, 
and to calculate the true error rate. We tested for statisti-
cally significant differences in error rates among DMSO 
treatments using a proportion test. Because reference- based 
approaches to error estimation face limitations, we imple-
mented a reference- free approach to error estimation [27]. We 
calculated the error rate for each of our DMSO treatments, as 
implemented in the R package ShadowRegression, and tested 
for differences using robust linear regressions.
rESulTS anD DIScuSSIOn
Our findings show that DMSO treatment has a dramatic 
effect on dsRNA sequencing (Table 1). When we prepared 
viral lysates for sequencing without DMSO, we did not obtain 
sufficient reads to cover the entire Φ6 genome. Treatment with 
15 % DMSO increased the number of mapping reads over 
sevenfold, whilst the 50 and 90 % treatments increased the 
number of reads by over two orders of magnitude, allowing 
the full genome to be sequenced at high coverage (mean read 
depth of 1727 for 50 % DMSO and 1493 for 90 % DMSO).
These increases in genome coverage occurred despite very low 
starting nucleic acid concentrations. We used a Qubit RNA 
high sensitivity assay kit to quantify RNA immediately after 
extraction; in all cases RNA was undetectable and so assumed 
to be under the kit’s limit of detection of 5 ng µl−1. Addition-
ally, we used a Qubit DNA high sensitivity assay kit to quan-
tify the amount of cDNA synthesized. Despite this kit’s lower 
limit of detection of 200 pg µl−1, DNA was still not detected. 
Thus, for dsRNA, the raw quantity of starting material may 
not be as important as the efficiency of cDNA synthesis, a 
fact that should accounted for when preparing quality- control 
thresholds before next- generation sequencing.
We next sought to determine whether DMSO treatment 
affected other types of RNA present in the sample, which 
would occur in metagenomes, clinical samples or transcrip-
tomes. DMSO treatment did not appear to affect the recovery 
of ssRNA- derived reads from the influenza virus genome. 
There was no discernible effect when the DMSO concentra-
tion was varied (Table 1). The number of reads mapping to the 
reference genome did decrease from the 0 % DMSO treatment 
to the 15 % DMSO treatment. However, this loss in mapping 
reads was most likely caused by the extra column clean-
 up step required to remove the DMSO (note that the total 
number of reads also decreased). We note that this decrease 
in reads in the influenza virus sequencing was less than one 
order of magnitude and still resulted in extremely high read 
depth, with a mean of over 1000× for every influenza segment 
after DMSO treatment (Table 2). This effect was obscured in 
Φ6 due to the large increase in mapping reads from DMSO 
treatment.
In order to determine whether the presence of DMSO affected 
any other properties of the RNA when used for downstream 
sequencing, we plotted the coverage at every nucleotide 
position for each DMSO concentration used. The plot for 
influenza (Fig. 1) showed a distinct, repeating pattern for each 
segment, with DMSO concentration appearing to have no 
effect on relative coverage. This indicates that there is no bias 
in which reads are affected by the DMSO treatment, and that 
the reads generated are still representative. A similar pattern 
could be observed for the 50 and 90 % DMSO treatments of 
Φ6 (Fig. 2; the low number of reads made this pattern harder 
to discern in the 15 % treatment). Therefore, DMSO treatment 
did not adversely affect genome- wide coverage patterns of 
dsRNA or ssRNA viruses.
To determine whether this method worked with higher starting 
concentrations of RNA, we used an Amicon centrifugal 
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Table 2. The mean read depth for each influenza segment under 
varying concentrations of DMSO
DMSO 
(%)
Total no. of reads Reads that map to 
influenza
Reads that map 
(%)
0 1 614 418 931 915 57.7
15 1 369 886 353 752 25.8
50 1 510 801 295 244 19.5
90 1 257 059 446 549 35.5
Fig. 1. DMSO treatment does not affect sequencing read coverage across the ssRNA influenza genome. The read depth at each position 
in the influenza genome under varying concentrations of DMSO is shown. Note that 8000 is the maximum read depth supported by the 
SAM/BAM file format, so some peaks in the 0 % DMSO plots have been truncated.
filter unit to concentrate approximately 10 ml Φ6 lysate into 
50 µl. The concentrated lysate contained 37.6 ng RNA µl−1 
(measured by Qubit) and was prepared for sequencing using 
90 % DMSO (as above), as well as a control without DMSO 
(heat treated for 90 min at 65 °C). While only 0.08 % of reads 
mapped to the reference genome in the non- DMSO treated 
control, there was an increase to 72.45 % in the DMSO- treated 
sample, again demonstrating the importance of the DMSO 
treatment over raw RNA concentration (Fig. 3). The concen-
trated sample had a much higher proportion of reads than the 
non- concentrated sample (16.1 %; Table 1), most likely due 
to the concentration step increasing the ratio of viral RNA 
to extracapsular RNA. Therefore, DMSO treatment works 
at varying RNA concentrations and is likely to improve any 
dsRNA sequencing regardless of starting concentration.
We also tested whether DMSO treatment was more effective 
than simple heat denaturation. We extracted RNA from Φ6 
and divided it into two aliquots. One of these was treated with 
50 % DMSO as described above, while the other was placed 
in boiling water for 5 min. After cDNA synthesis, library 
preparation and sequencing, we mapped the resulting reads to 
the Φ6 reference genome. In the heat- treated sample, 1.72 % 
of reads successfully mapped to the reference, whilst in the 
DMSO- treated sample this increased to 40.24 %. While heat 
denaturation is clearly of some benefit (compared to 0.08 % 
of reads mapped in the no- treatment control), these data 
demonstrate that DMSO treatment is the superior method 
and might be vital when working with low starting RNA 
concentrations.
Because the fidelity of reverse transcriptase reactions relies 
on base- pairing, we examined whether DMSO treatment had 
any effect on fidelity by searching for errors in the sequence 
data using two approaches. First, we extracted all bases that 
were different from the reference genome with Phred quality 
score of at least 30. This per- base quality score is equivalent 
to an expected error rate of 0.1%, meaning over the entire 
genome sequence the expectation would be 1/1000 bases to 
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Fig. 2. DMSO treatment greatly increases sequence coverage of the dsRNA Φ6 genome. Read depth at each position in the Φ6 genome 
under varying concentrations of DMSO is shown. There were insufficient reads to generate a plot for 0 % DMSO.
be sequencing errors. Under the assumption that all differ-
ences from the reference were errors, these data were used to 
calculate the true error rate. This error rate was converted to 
a Phred score (Table 3). If DMSO increased the sequencing 
error rate, we would expect our calculated Phred score to 
decrease as DMSO concentration is increased. There was a 
statistically significant difference in error rates for each DMSO 
treatment of Φ6 (X2=533.6, df=2, P<2.2×10−16); however, the 
error rate did not increase with increasing DMSO concentra-
tion (the untreated, control Φ6 sample did not have enough 
reads for comparison). Similarly, for influenza, the difference 
in error rates was statistically significant (X2=575.08, df=3, 
P<2.2×10−16), but numerically miniscule (Table  3). More-
over, the error rate decreased as the DMSO concentration 
increased. In all cases, the true error rate was lower than the 
expected error rate. Additionally, our calculated error rate is 
conservative, because of the assumption that all differences 
from the reference were erroneous. In actuality, some of these 
differences at low frequency could be true mutations in RNA 
virus populations (i.e. minor variants).
Second, to estimate error rates in short reads without a refer-
ence genome, we also used the ShadowRegression R package 
[27], which compares reads against each other. Our data show 
that DMSO has little effect on the error rate of the ssRNA 
influenza virus (Fig. 4). Using a robust F- test, we found that the 
difference in influenza error rate between each DMSO- treated 
sample and the untreated sample was not statistically signifi-
cant (15% DMSO, F=1.4003, P=0.134; 50 % DMSO, F=2.246, 
P=0.2367; 90 % DMSO, F=0.2093, P=0.6473). Moreover, 
these error rates did not show any pattern with increasing 
DMSO concentration (Fig. 4a, inset). However, in Φ6 we 
found that as the concentration of DMSO increased, the 
sequencing error rate actually decreased (Fig. 4b, inset). This 
decrease compared to the 15 % DMSO treatment was statisti-
cally significant (50 % DMSO, F=280.95, P<2.2×10−16; 90 % 
DMSO, F=37.391, P=1.092×10−9). Thus, using two statistical 
approaches, these data collectively indicate that DMSO did 
not have an adverse effect on read accuracy and in some 
instances may improve sequencing accuracy.
The mock viral community (NIBSC reagent 11/242–001) was 
made by mixing 25 eukaryotic viruses [17]. Of those with 
RNA genomes, the most abundant in the sample is thought 
to be the dsRNA rotavirus, based on real- time PCR results 
[25], which we selected for comparison with the ssRNA virus 
human parechovirus 3. Using a virus discovery pipeline, we 
only detected 1 read from a dsRNA virus (rotavirus A) in the 
sample untreated with DMSO (Table 4). However, under the 
15 % DMSO treatment, this increased to over 203 rotavirus 
reads, as well as reads from dsRNA viruses not thought to 
have been in the reagent, including human picobirnavirus 
and some totiviruses. This result is notable because the mock 
viral community was made such that rotavirus A was the most 
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Fig. 3. DMSO treatment has a greater effect than RNA concentration on generating dsRNA reads using next- generation sequencing. 
The percentages of sequencing reads mapping to the Φ6 reference genome are shown with no treatment (Untreated), concentration 
(Concentrated), nuclease treatment (Nuclease), nuclease treatment and concentration (Concentrated Nuclease), nuclease and DMSO 
treatments and concentration (Concentrated Nucelase DMSO), and nuclease and DMSO treatments (Nuclease DMSO).
Table 3. The error rate and quality score for each of the Φ6 and influenza samples treated with DMSO. The error rate was not determined for Φ6 0% 
DMSO, because this treatment generated insufficient reads (see Table 1).
Organism DMSO (%) Total no. of errors Total no. of bases sequenced Error rate (%) Phred quality 
score
Φ6 0 not determined not determined not determined not determined
15 176 857 974 0.021 36.9
50 8 940 23 127 006 0.039 34.1
90 5 276 19 996 871 0.026 35.8
Influenza 0 34 527 68 561 988 0.050 33.0
15 13 181 29 087 984 0.045 33.4
50 9 549 23 120 765 0.041 33.8
90 16 757 40 369 161 0.042 33.8
abundant virus [25]. If the most abundant virus can be so 
under- represented in a known sample, this suggests many 
metagenomic studies will miss almost all dsRNA viruses. 
Furthermore, we indeed find dsRNA viruses that had previ-
ously evaded detection in the mock viral community [17]. 
The 50 and 90 % DMSO treatments contained significantly 
fewer dsRNA reads than the 15 % treatment, but reads from all 
viruses were reduced in these samples. Although the number 
of reads detected in the DMSO- treated samples were low 
compared with the untreated sample, dsRNA was practically 
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Fig. 4. DMSO treatment does not adversely affect sequencing error rates in influenza (a) or Φ6 (b). The R package ShadowRegression 
estimates reference- free error rates (inset) based on a transform of the slope of read counts and their ‘shadows’ (main plot line graphs).
Table 4. Total number of reads detected in reagent 11/242–001 under 




Parechovirus hits Rotavirus A hits Other dsRNA virus 
hits
0 3263 1 0
15 2089 203 27
50 293 10 9
90 785 11 4
undetectable in the latter. Therefore, despite some caveats, we 
suggest that the power of this method for detecting dsRNA 
viruses in metagenomic samples is clear.
conclusion
Sequencing of dsRNA can frequently be problematic, with 
traditional cDNA synthesis being highly inefficient. We 
have demonstrated that a simple treatment with a cheap 
and common laboratory reagent can increase the number of 
sequencing reads from dsRNA organisms by over two orders 
of magnitude. Importantly, the positive effect of the DMSO 
treatment occurred independent of RNA concentration, even 
when RNA was undetectable. Furthermore, DMSO treatment 
was more important than RNA concentration in determining 
dsRNA read yield and it did not affect viral genome coverage. 
We suggest that samples to be sequenced that contain or are 
suspected to contain dsRNA are treated with at least 50 % 
DMSO prior to cDNA synthesis. This treatment should also 
improve sequencing of dsRNA involved in innate immunity 
in plants and animals. We suspect this treatment can be 
successfully applied to other DNA sequencing technologies, 
because the DMSO treatment occurs at the cDNA synthesis 
step and has been shown to improve other procedures, such 
as Sanger sequencing [12].
When preparing an environmental sample for sequencing, it 
is possible that there may be dsRNA viruses present that are 
undetectable when following standard protocols. Previous 
data have shown dsRNA viruses to be under- represented 
in metagenomic samples [25]. Our data on the mock viral 
community (where the putatively most abundant virus was 
not detected without DMSO treatment) suggests dsRNA 
viruses will almost invariably go undetected in environmental 
samples. We have shown that not only will DMSO treatment 
increase representation of these organisms, but also the effect 
on ssRNA representation is minor. It may well be that dsRNA 
viruses are more numerous than thought, but remain unde-
tected using traditional methods.
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